Agile Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AGXRW for the last quarter is 5.72 M USD, and it's 58.12% higher compared to the previous quarter. The net income of Q1 24 is 1.28 M USD.